nebulized or aerosolized glutathione Advances in Inhaled Nanoparticle Drug Delivery for Pulmonary Disease Management Overcoming barriers to delivery of
Description
Overcoming oxidative stress in a redox environment is applicable to treatment outcome
PMID: 24615780
The findings of clinical and basic studies indicate that subjects with MHO do not exhibit an increased mortality, an increased risk of cardiovascular disease, or an increased risk of type 2 diabetes mellitus, as compared to normal-weight controls
doi: 10.1186/s12870-015-0500-y 45 WuY.WangW
10.1111/j.1439-0434.2004.00884.x 86 LamoureuxG
